Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial–mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosisMiki Yamaguchi, Yuji Sakuma|Laboratory Investigation|2016Cited by 74
WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitorsYuji Sakuma, Yohei Miyagi|Laboratory Investigation|2011Cited by 47
Survivin knockdown induces senescence in TTF‑1-expressing, KRAS-mutant lung adenocarcinomasToshiyuki Sumi, Yuji Sakuma|International Journal of Oncology|2018Cited by 21
A Newly Developed Anti-L1CAM Monoclonal Antibody Targets Small Cell Lung Carcinoma CellsMiki Yamaguchi, Yuji Sakuma|International Journal of Molecular Sciences|2024Cited by 4